You are here

Heptares Therapeutics

Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei

Endpoints

Tue, 03/13/18 - 10:13 am

Teva Pharmaceutical

drug development

Heptares Therapeutics

Heptares nabs $5M from Teva for new migraine molecule

Fierce Biotech

Thu, 05/18/17 - 10:09 am

Heptares Therapeutics

drug development

Teva Pharmaceutical

Solo again, Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio

Fierce Biotech

Thu, 04/7/16 - 10:07 am

Heptares Therapeutics

Alzheimer's disease

Heptares plans Alzheimer's PhII; AstraZeneca ends I-O trial rollout; 4D buys microbiome firm

Fierce Biotech

Fri, 02/12/16 - 09:51 am

Heptares Therapeutics

AstraZeneca Oncology Partnerships To Help Recover Sales

Bidness ETC

Tue, 08/25/15 - 09:43 am

Peregrine Pharmaceuticals

Heptares Therapeutics

Mirati Therapeutics

Juno Therapeutics

AstraZeneca plc (ADR) Strikes 2 Immuno-Oncology Deals; Are Its Efforts In The Right Direction?

Bidness, ETC

Fri, 08/7/15 - 10:56 am

immuno-oncology

Heptares Therapeutics

Mirati Therapeutics

Value of AstraZeneca's immuno-oncology deal could top $500M

Bizjournals.com

Thu, 08/6/15 - 12:14 pm

immuno-oncology

Heptares Therapeutics

The 15 most promising biotech companies

Fierce Pharma

Mon, 06/29/09 - 03:41 pm

Agios Pharmaceuticals

Calistoga Pharmaceuticals

Clovis Oncology

Heptares Therapeutics

Pacific Biosciences

Portola Pharmaceuticals

Proteon Therapeutics